Serum 25-hydroxyvitamin D measurement in a large population survey with statistical harmonization of assay variation to an international standard

被引:58
作者
Hypponen, Elina
Turner, Steve
Cumberland, Phillippa
Power, Christine
Gibb, Ian
机构
[1] Inst Child Hlth, Ctr Pediat Epidemiol & Biostat, London WC1N 1EH, England
[2] Royal Victoria Infirm, Newcastle Upon Tyne Hosp Natl Hlth Serv Trust, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England
基金
英国医学研究理事会;
关键词
D O I
10.1210/jc.2007-1279
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Context: An automated application of Immunodiagnostic Systems Limited ( IDS) OCTEIA 25-hydroxyvitamin D [ 25( OH) D] enzyme immunoassay was developed for analyses of 25( OH) D in more than 7000 participants of the 1958 cohort. Variation between 25( OH) D assays hampers between-study comparisons and the definition of relevant cutoffs for hypovitaminosis D. Objective: The objective of the study was to evaluate the importance of assay variation on the estimated prevalence of hypovitaminosis D and assess the use of statistical harmonization to overcome the observed differences. Design: Agreement analyses were performed between two commercial 25( OH) D assays ( IDS enzyme immunoassay and Diasorin RIA), with validation using performance data from Vitamin D External Quality Assessment Scheme ( DEQAS). Setting: The study was conducted in England, Scotland, and Wales. Participants: Members of the 1958 British birth cohort participated in the study. Main Outcome Measures: 25( OH) D was measured both by IDS and Diasorin RIA in 781 samples. Additional quality control data were obtained through participation in DEQAS( five distributions throughout the survey). Results: Average 25( OH) D concentrations by IDS were -15.7 and -13.7 nmol/liter lower, compared with Diasorin or DEQAS mean, respectively ( both P < 0.0001). Graphical examination demonstrated a dose-related bias between IDS with Diasorin and DEQAS mean, but log transformation removed the bias. After using the log difference between the measurements as an adjustment factor, there were no differences in average 25( OH) D concentrations ( P >= 0.21 for comparison of IDS with Diasorin or DEQAS) and estimates for hypovitaminosis D obtained by IDS were similar to Diasorin. Conclusions: Differences between assays have implications for public health messages about hypovitaminosis D. Harmonization of results with DEQAS enabled the use of previously determined cutoffs for hypovitaminosis D.
引用
收藏
页码:4615 / 4622
页数:8
相关论文
共 25 条
[1]
[Anonymous], 1963, Perinatal mortality : the first report of the 1958 British perinatal mortality survey, under the auspices of the National Birthday Trust Fund
[2]
Antoniucci DM, 2005, CLIN CHEM, V51, P258
[3]
Assay variation confounds the diagnosis of hypovitaminosis D: A call for standardization [J].
Binkley, N ;
Krueger, D ;
Cowgill, CS ;
Plum, L ;
Lake, E ;
Hansen, KE ;
DeLuca, HF ;
Drezner, MK .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (07) :3152-3157
[4]
Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes [J].
Bischoff-Ferrari, Heike A. ;
Giovannucci, Edward ;
Willett, Walter C. ;
Dietrich, Thomas ;
Dawson-Hughes, Bess .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2006, 84 (01) :18-28
[5]
Measuring agreement in method comparison studies [J].
Bland, JM ;
Altman, DG .
STATISTICAL METHODS IN MEDICAL RESEARCH, 1999, 8 (02) :135-160
[6]
The anomalous behaviour of exogenous 25-hydroxyvitamin D in competitive binding assays [J].
Carter, G. D. ;
Jones, J. C. ;
Berry, J. L. .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2007, 103 (3-5) :480-482
[7]
How accurate are assays for 25-hydroxyvitamin D? Data from the international vitamin D external quality assessment scheme [J].
Carter, GD ;
Carter, R ;
Jones, J ;
Berry, J .
CLINICAL CHEMISTRY, 2004, 50 (11) :2195-2197
[8]
Estimates of optimal vitamin D status [J].
Dawson-Hughes, B ;
Heaney, RP ;
Holick, MF ;
Lips, P ;
Meunier, PJ ;
Vieth, R .
OSTEOPOROSIS INTERNATIONAL, 2005, 16 (07) :713-716
[9]
Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON® automated analyzer [J].
Ersfeld, DL ;
Rao, DS ;
Body, JJ ;
Sackrison, JL ;
Miller, AB ;
Parikh, N ;
Eskridge, TL ;
Polinske, A ;
Olson, GT ;
MacFarlane, GD .
CLINICAL BIOCHEMISTRY, 2004, 37 (10) :867-874
[10]
Current assays overestimate 25-hydroxyvitamin D3 and underestimate 25-hydroxyvitamin D2 compared with HPLC:: need for assay-specific decision limits and metabolite-specific assays [J].
Glendenning, P ;
Taranto, M ;
Noble, JM ;
Musk, AA ;
Hammond, C ;
Goldswain, PR ;
Fraser, WD ;
Vasikaran, SD .
ANNALS OF CLINICAL BIOCHEMISTRY, 2006, 43 :23-30